BPU
BPU arrests cell cycle progression in the sub-G1 phase. BPU is an anticancer agent through inhibiting blood vessel formation in tumor tissues[1].
Product Specifications
UNSPSC
12352005
Target
Apoptosis; MMP
Type
Reference compound
Related Pathways
Apoptosis; Metabolic Enzyme/Protease
Applications
Cancer-Kinase/protease
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/bpu.html
Purity
99.04
Solubility
DMSO : 200 mg/mL (ultrasonic)
Smiles
O=C(N)N(C1=NC=C(Br)N=C1)CC2=CC=CC(C(F)(F)F)=C2
Molecular Formula
C13H10BrF3N4O
Molecular Weight
375.14
References & Citations
[1]Yasser Hussein Issa Mohammed, et al. Discovery of 1- (5-bromopyrazin-2-yl) -1-[3- (trifluoromethyl) benzyl]urea as a promising anticancer drug via synthesis, characterization, biological screening, and computational studies. Sci Rep. 2023, 13, 1.|[2]Yasser Hussein Issa Mohammed, et al. Discovery of 1- (5-bromopyrazin-2-yl) -1-[3- (trifluoromethyl) benzyl]urea as a promising anticancer drug via synthesis, characterization, biological screening, and computational studies. Scientific Reports. Dec 12.
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
LC429147 20 µg
Kv beta 1 (KCNAB1) (NM_003471) Human Over-expression Lysate
Sign In for Pricing
View Details 
LC424863 20 µg
Iduronate 2 suLfatase (IDS) (NM_000202) Human Over-expression Lysate
Sign In for Pricing
View Details 